Search Results

Filter
  • 1-10 of  1,897 results for ""Gangliosides immunology""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis.

  • Authors : Noioso CM; Neurology Unit, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', University of Salerno, Salerno, Italy. .; Bevilacqua L

Subjects: Miller Fisher Syndrome*/Miller Fisher Syndrome*/Miller Fisher Syndrome*/diagnosis ; Miller Fisher Syndrome*/Miller Fisher Syndrome*/Miller Fisher Syndrome*/immunology ; Miller Fisher Syndrome*/Miller Fisher Syndrome*/Miller Fisher Syndrome*/blood

  • Source: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Dec; Vol. 45 (12), pp. 5657-5669. Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prospects of anti-GD2 immunotherapy for retinoblastoma.

  • Authors : Zhang X; Affiliated Hospital of Shandong Second Medical University,School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.; Jinming Yu Academician Workstation of Oncology, Shandong Second Medical University, Shandong, China.

Subjects: Retinoblastoma*/Retinoblastoma*/Retinoblastoma*/therapy ; Retinoblastoma*/Retinoblastoma*/Retinoblastoma*/immunology ; Gangliosides*/Gangliosides*/Gangliosides*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Nov 15; Vol. 15, pp. 1499700. Date of Electronic Publication: 2024 Nov 15 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Immunoliposomes for Neuroblastoma: Review of the Past Experience and Design of a Novel Nanoparticle.

  • Authors : Panosyan WS; University of California Los Angeles, UCLA College of Letters & Science, Los Angeles, CA, U.S.A. .; Panosyan DE

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/drug therapy ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/immunology ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/metabolism

  • Source: Anticancer research [Anticancer Res] 2024 Nov; Vol. 44 (11), pp. 4665-4675.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

GD2 in Breast Cancer: A Potential Biomarker and Therapeutic Target.

  • Authors : Mokbel K; The London Breast Institute, Princess Grace Hospital, London, U.K. .

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism

  • Source: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2024 Nov-Dec; Vol. 21 (6), pp. 549-556.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 101188791 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Enhanced anti-tumor activity mediated by combination chimeric antigen receptor T cells targeting GD2 and GPC2 in high-risk neuroblastoma.

  • Authors : Wu H; Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases, and Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China; Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, China.

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/therapy ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/immunology ; Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/immunology

  • Source: Cytotherapy [Cytotherapy] 2024 Nov; Vol. 26 (11), pp. 1308-1319. Date of Electronic Publication: 2024 May 31.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566

Record details

×
Academic Journal

Omalizumab for Treatment of Anti-GD2 Antibody-related Urticaria.

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Urticaria*/Urticaria*/Urticaria*/drug therapy ; Urticaria*/Urticaria*/Urticaria*/immunology

  • Source: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2024 Oct 01; Vol. 46 (7), pp. e531-e533. Date of Electronic Publication: 2024 Aug 22.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Tumor necrosis factor α receptor 1A transduces the inhibitory effect on axon regeneration triggered by IgG anti-ganglioside GD1a antibodies.

  • Authors : Báez BB; Departamento de Química Biológica 'Dr Ranwel Caputto', Facultad de Ciencias Químicas, Universidad Nacional de Córdoba-CIQUIBIC-CONICET-UNC, Argentina; Laboratorio de Neurobiología, Instituto de Investigación Médica Mercedes y Martin Ferreyra, INIMEC-CONICET, Universidad Nacional de Córdoba, Argentina.

Subjects: Axons*/Axons*/Axons*/metabolism ; Axons*/Axons*/Axons*/immunology ; Gangliosides*/Gangliosides*/Gangliosides*/metabolism

  • Source: Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2024 Oct; Vol. 1870 (7), pp. 167315. Date of Electronic Publication: 2024 Jun 17.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731730 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Protocol for assessing GD2 on formalin-fixed paraffin-embedded tissue sections using immunofluorescence staining.

  • Authors : Kailayangiri S; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Subjects: Paraffin Embedding*/Paraffin Embedding*/Paraffin Embedding*/methods ; Formaldehyde*/Formaldehyde*/Formaldehyde*/chemistry ; Fluorescent Antibody Technique*/Fluorescent Antibody Technique*/Fluorescent Antibody Technique*/methods

  • Source: STAR protocols [STAR Protoc] 2024 Sep 20; Vol. 5 (3), pp. 103199. Date of Electronic Publication: 2024 Jul 22.Publisher: Cell Press Country of Publication: United States NLM ID: 101769501 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma.

  • Authors : Pascual-Pasto G; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.; McIntyre B

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/immunology ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/therapy ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology

  • Source: Nature communications [Nat Commun] 2024 Aug 21; Vol. 15 (1), pp. 7141. Date of Electronic Publication: 2024 Aug 21.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers.

  • Authors : Fischer-Riepe L; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.; Kailayangiri S

Subjects: Gangliosides*/Gangliosides*/Gangliosides*/immunology ; Interleukin-18*/Interleukin-18*/Interleukin-18*/metabolism ; Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/immunology

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3564-3577.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  1,897 results for ""Gangliosides immunology""